Cancer is an extremely horrible illness that affects countless people throughout the world. One type, breast cancer usually penetrates women but can also target men, and in the past meant death for people who were diagnosed with the disease. Yet, as technological innovations have been released and early detection has increased, if found in time you can usually overcome it.
For those of you out there who are already getting yearly mammograms, another tool you could use is a new bra from Nevada-based First Warning Systems that can let a woman know if she has breast cancer. When wearing the material that covers your bosoms for around 12 hours, heat sensors go to work and can quickly alert the female if there are temperature changes in their tissue which is usually a sign of a tumor.
“The thermoster sends a low impedance scan through the breast and reports back as a temperature," Matt Bernadis with First Warning, told ABC News in San Francisco, Calif. “Against the screening mammogram we're finding the mammogram was accurate up to about 70 percent on average, whereas the First Warning System was accurate to about 90 percent, 90 percent-plus.”
Although this next-generation bra could help to reduce the amount of people being faced with the news that they have breast cancer, it is not and I repeat not to be used in substitution of regular doctor visits and mammograms but rather in conjunction.
According to Dr. David Priest, director of Women's Imaging at St. Mary's Medical Center in San Francisco, a negative side of this solution is that it could not be completely accurate and would in turn women to rush to get mammograms when they aren’t actually needed, exposing them to a high level of radiation.
One company making strides in protecting women’s tatas is GE Healthcare. It is doing what it can to help physicians with breast cancer patients and some of its new solutions including improving screening related to this disease and range to creating products that more quickly diagnose those who are suffering from it, ultimately meaning the difference between life and death.
Chief Executive Officer of Clarient Diagnostic Services (a GE Healthcare company) Carrie Eglinton-Manner stated, “With a disease as complex and multi-faceted as breast cancer, innovations need to be equally multi-faceted and even more integrated in their scope, and GE Healthcare is fully committed to developing solutions that enable physicians to improve the quality of care provided to the patients they treat.”
To read the full report, click here.
Edited by Stefanie Mosca